NCT06921720View on ClinicalTrials.gov

Phosphorus-31 Spectroscopy in Phosphate Diabetes

NANot yet recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

May 1, 2027

Conditions
Phosphate DiabetesX-linked Hypophosphatemia
Interventions
DIAGNOSTIC_TEST

intra-muscular ATP values in phosphate diabetes

intra-muscular ATP values \[ATPi\] (measured by 31P-MRS / Phosphorus-31 nuclear magnetic resonance) at rest and during standardized exercise in patients with phosphate diabetes.

DIAGNOSTIC_TEST

intra-muscular phosphate values in phosphate diabetes

intra-muscular phosphate values (measured by 31P-MRS) at rest and during standardized exercise in patients with phosphate diabetes.

Trial Locations (2)

69003

Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon

69500

Hôpital femme mère enfant, hospices civils de Lyon, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER